Matrices & Trackers
Comparison Chart: NIH Pre-Award and Post-Award Disclosures Relating to the Biographical Sketch and Other Support
This document compares the June 2022 version of the NIH Pre-award and Post-award Disclosures Relating to the Biographical Sketch and Other Support with the prior version of the chart related by NIH.
Regulatory Review Chart - Pending Regulatory Freeze
The document provides a detailed account of federal rules, regulations, and executive orders that were either revoked, paused, or placed under review following the January 20, 2021, Regulatory Freeze Pending Review Presidential Memorandum, issued at the start of the Biden administration. Major actions included the revocation of prior executive orders such as EO 13950, which addressed race and sex
COGR Research Regulatory Reform Matrix
The document provides a detailed overview of federal efforts to address regulatory burden and reform policies related to federally funded research, based on statutory requirements from acts such as the 21st Century Cures Act and the American Innovation and Competitiveness Act (AICA). Key reform areas include the establishment of a Research Policy Board, interagency working groups, harmonization of
Overview of the Final Revised Common Rule
February 1, 2017: An overview of the changes to the revised Common Rule published in the Federal Register on January 19, 2017, a one page summary table of the changes made, and a link to the final revised Common Rule.
COGR Common Rule Summary Table
The Common Rule Summary Table outlines significant revisions to federal regulations governing human subjects research. The final rule, effective from January 19, 2018 (with special provisions for cooperative research effective January 20, 2020), distinguishes between non-identified and identifiable biospecimens, treating identifiable biospecimens and private information equivalently and providing
Regulatory_Changes_Since_1991
The document, produced by the Council on Governmental Relations (COGR), provides a comprehensive overview of federal regulatory changes affecting the conduct and management of research under federal grants and contracts since the 1991 imposition of a 26% cap on administrative costs in Facilities and Administrative (F&A) cost recovery. Organized chronologically, it lists significant regulations
